lobbying_activities: 2143515

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2143515	d9625fe6-46dc-456e-8b4f-4121ff868ce3	Q2	MS. TAMI WAHL	401104405	ROCK & ASSOCIATES	2018	second_quarter	PHA	Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2018-07-13T10:40:36.687000-04:00